These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 16732707

  • 1. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
    Fox K.
    Expert Opin Pharmacother; 2006 Jun; 7(9):1211-20. PubMed ID: 16732707
    [Abstract] [Full Text] [Related]

  • 2. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A, Tardif JC.
    Adv Cardiol; 2006 Jun; 43():65-78. PubMed ID: 16936473
    [Abstract] [Full Text] [Related]

  • 3. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
    Sulfi S, Timmis AD.
    Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
    [Abstract] [Full Text] [Related]

  • 4. Clinical results of I(f) current inhibition by ivabradine.
    Tardif JC.
    Drugs; 2007 Feb; 67 Suppl 2():35-41. PubMed ID: 17999562
    [Abstract] [Full Text] [Related]

  • 5. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W, Tendera M, Ford I, Fox KM.
    Drugs; 2007 Feb; 67(3):393-405. PubMed ID: 17335297
    [Abstract] [Full Text] [Related]

  • 6. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A, de Silva R.
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [Abstract] [Full Text] [Related]

  • 7. Ivabradine: beyond heart rate control.
    Riccioni G, Vitulano N, D'Orazio N.
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
    Müller-Werdan U, Stöckl G, Ebelt H, Nuding S, Höpfner F, Werdan K, ADDITIONS Study Investigators.
    Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
    [Abstract] [Full Text] [Related]

  • 14. Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
    Chaitman BR, Sano J.
    Clin Cardiol; 2007 Feb; 30(2 Suppl 1):I25-30. PubMed ID: 18373327
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS, Le Heuzey JY.
    Am J Ther; 2008 Feb; 15(5):461-73. PubMed ID: 18806523
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.
    Werdan K, Ebelt H, Nuding S, Höpfner F, Stöckl G, Müller-Werdan U.
    Adv Ther; 2015 Feb; 32(2):120-37. PubMed ID: 25687888
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Focus on ivabradine: a new heart rate-controlling drug.
    Riccioni G.
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.